JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

University of Pittsburgh Medical Center, Pittsburgh

Penn State Hershey Medical Center, Hershey

Duke University Hospital, Durham

Medical University of South Carolina, Charleston

Emory University, Atlanta

Medizinische Hochschule Hannover (MHH), Hanover

Mayo Clinic Florida, Jacksonville

Central Florida Pulmonary Group, PA, Orlando

Lungenfachklinik Immenhausen, Immenhausen

Justus-Liebig-Universitaet Giessen, Giessen

Norton Clinical Research Group, Louisville

University of Minnesota Medical School, Minneapolis

Loyola University Medical Center, Maywood

OSF HealthCare Saint Francis Medical Center, Peoria

Thoraxklinik-Heidelberg gGmbH, Heidelberg

UT Southwestern Medical Center, Dallas

UT Health San Antonio: First Outpatient Research Unit, San Antonio

Universitatsklinikum Freiburg, Freiburg im Breisgau

University of Utah Health, Salt Lake City

Cedars-Sinai Medical Center, Los Angeles

Amicis Research Center, Northridge

University of California, San Francisco, Medical Center at Parnassus, San Francisco

National Hospital Organization Kinki-chuo Chest Medical Center, Osaka

Banner-University Medical Center Tucson Campus, Tucson

Massachusetts General Hospital, Boston

Dartmouth-Hitchcock Medical Center (DHMC), Lebanon

University of Washington, Seattle

Ruhrlandklinik, Universitatmedzin Essen, Essen

National Hospital Organization Himeji Medical Center, Himeji-Shi

National Hospital Organization Ibarakihigashi National Hospital, Naka-gun

Kanagawa Cardiovascular and Respiratory Center, Yokohama

Tosei General Hospital, Aichi

Royal Papworth Hospital NHS Foundation Trust, Cambridge